Services

Preclinical Modelling

Organo-ID provides preclinical models of the below using eHEPO organoid technology;

• Metabolic liver disease
• Rare diseases such as Citrulinemia, Pyruvate decarboxylase

Drug response prediction for personalized treatment

Organo-ID focuses for the production of PDCO’s to test tumor’s response to the drugs for individual patients and to report which help oncologists to lead a more individual and personalized cancer treatment.